docetaxel anhydrous has been researched along with phenethyl isothiocyanate in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (phenethyl isothiocyanate) | Trials (phenethyl isothiocyanate) | Recent Studies (post-2010) (phenethyl isothiocyanate) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 501 | 7 | 231 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | phenethyl isothiocyanate (IC50) |
|---|---|---|---|
| Macrophage migration inhibitory factor | Homo sapiens (human) | 1.6 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 7.5 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 7.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, SV; Xiao, D | 1 |
1 other study(ies) available for docetaxel anhydrous and phenethyl isothiocyanate
| Article | Year |
|---|---|
Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Docetaxel; Drug Interactions; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Male; Mice; Mice, Nude; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Taxoids | 2010 |